These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 26702150)
1. Therapeutic potential of an orally effective small molecule inhibitor of plasminogen activator inhibitor for asthma. Liu RM; Eldridge S; Watanabe N; Deshane J; Kuo HC; Jiang C; Wang Y; Liu G; Schwiebert L; Miyata T; Thannickal VJ Am J Physiol Lung Cell Mol Physiol; 2016 Feb; 310(4):L328-36. PubMed ID: 26702150 [TBL] [Abstract][Full Text] [Related]
2. IMD-4690, a novel specific inhibitor for plasminogen activator inhibitor-1, reduces allergic airway remodeling in a mouse model of chronic asthma via regulating angiogenesis and remodeling-related mediators. Tezuka T; Ogawa H; Azuma M; Goto H; Uehara H; Aono Y; Hanibuchi M; Yamaguchi Y; Fujikawa T; Itai A; Nishioka Y PLoS One; 2015; 10(3):e0121615. PubMed ID: 25785861 [TBL] [Abstract][Full Text] [Related]
3. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells. Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258 [TBL] [Abstract][Full Text] [Related]
4. Inhalation of urokinase-type plasminogen activator reduces airway remodeling in a murine asthma model. Kuramoto E; Nishiuma T; Kobayashi K; Yamamoto M; Kono Y; Funada Y; Kotani Y; Sisson TH; Simon RH; Nishimura Y Am J Physiol Lung Cell Mol Physiol; 2009 Mar; 296(3):L337-46. PubMed ID: 19098125 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic value of small molecule inhibitor to plasminogen activator inhibitor-1 for lung fibrosis. Huang WT; Vayalil PK; Miyata T; Hagood J; Liu RM Am J Respir Cell Mol Biol; 2012 Jan; 46(1):87-95. PubMed ID: 21852684 [TBL] [Abstract][Full Text] [Related]
6. A Small Molecule Inhibitor of Plasminogen Activator Inhibitor-1 Reduces Brain Amyloid-β Load and Improves Memory in an Animal Model of Alzheimer's Disease. Akhter H; Huang WT; van Groen T; Kuo HC; Miyata T; Liu RM J Alzheimers Dis; 2018; 64(2):447-457. PubMed ID: 29914038 [TBL] [Abstract][Full Text] [Related]
7. MFG-E8/integrin β3 signaling contributes to airway inflammation response and airway remodeling in an ovalbumin-induced murine model of asthma. Zhi Y; Huang H; Liang L J Cell Biochem; 2018 Nov; 119(11):8887-8896. PubMed ID: 30076648 [TBL] [Abstract][Full Text] [Related]
8. An orally active geranyl acetophenone attenuates airway remodeling in a murine model of chronic asthma. Lee YZ; Shaari K; Cheema MS; Tham CL; Sulaiman MR; Israf DA Eur J Pharmacol; 2017 Feb; 797():53-64. PubMed ID: 28089919 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of anti-immunoglobulin E antibodies on airway remodeling in a murine model of chronic asthma. Kang JY; Kim JW; Kim JS; Kim SJ; Lee SH; Kwon SS; Kim YK; Moon HS; Song JS; Park SH; Lee SY J Asthma; 2010 May; 47(4):374-80. PubMed ID: 20528589 [TBL] [Abstract][Full Text] [Related]
11. A plasminogen activator inhibitor-1 inhibitor reduces airway remodeling in a murine model of chronic asthma. Lee SH; Eren M; Vaughan DE; Schleimer RP; Cho SH Am J Respir Cell Mol Biol; 2012 Jun; 46(6):842-6. PubMed ID: 22323366 [TBL] [Abstract][Full Text] [Related]
12. Plasmin system regulation in an ovalbumin-induced rat model of asthma. Kucharewicz I; Mogielnicki A; Kasacka I; Buczko W; Bodzenta-Łukaszyk A Int Arch Allergy Immunol; 2008; 147(3):190-6. PubMed ID: 18594148 [TBL] [Abstract][Full Text] [Related]
13. Intra-airway administration of small interfering RNA targeting plasminogen activator inhibitor-1 attenuates allergic asthma in mice. Miyamoto S; Hattori N; Senoo T; Onari Y; Iwamoto H; Kanehara M; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Yokoyama A; Kohno N Am J Physiol Lung Cell Mol Physiol; 2011 Dec; 301(6):L908-16. PubMed ID: 21926267 [TBL] [Abstract][Full Text] [Related]
15. EC-18, a synthetic monoacetyldiglyceride (1-palmitoyl-2-linoleoyl-3-acetylglycerol), attenuates the asthmatic response in an aluminum hydroxide/ovalbumin-induced model of asthma. Shin IS; Shin NR; Jeon CM; Kwon OK; Sohn KY; Lee TS; Kim JW; Ahn KS; Oh SR Int Immunopharmacol; 2014 Jan; 18(1):116-23. PubMed ID: 24269625 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of airway inflammation, hyperresponsiveness and remodeling by soy isoflavone in a murine model of allergic asthma. Bao ZS; Hong L; Guan Y; Dong XW; Zheng HS; Tan GL; Xie QM Int Immunopharmacol; 2011 Aug; 11(8):899-906. PubMed ID: 21354484 [TBL] [Abstract][Full Text] [Related]
17. The presence of LPS in OVA inhalations affects airway inflammation and AHR but not remodeling in a rodent model of asthma. Tsuchiya K; Siddiqui S; Risse PA; Hirota N; Martin JG Am J Physiol Lung Cell Mol Physiol; 2012 Jul; 303(1):L54-63. PubMed ID: 22523281 [TBL] [Abstract][Full Text] [Related]
18. Vitex rotundifolia L. prevented airway eosinophilic inflammation and airway remodeling in an ovalbumin-induced asthma mouse model. Bae H; Kim Y; Lee E; Park S; Jung KH; Gu MJ; Hong SP; Kim J Int Immunol; 2013 Mar; 25(3):197-205. PubMed ID: 23171813 [TBL] [Abstract][Full Text] [Related]
19. PARP inhibition by olaparib or gene knockout blocks asthma-like manifestation in mice by modulating CD4(+) T cell function. Ghonim MA; Pyakurel K; Ibba SV; Al-Khami AA; Wang J; Rodriguez P; Rady HF; El-Bahrawy AH; Lammi MR; Mansy MS; Al-Ghareeb K; Ramsay A; Ochoa A; Naura AS; Boulares AH J Transl Med; 2015 Jul; 13():225. PubMed ID: 26169874 [TBL] [Abstract][Full Text] [Related]